BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2743373)

  • 21. [Course of ventricular arrhythmias following myocardial infarction. Results of a 2-year follow-up].
    Medvedowsky JL; Barnay C; Arnaud C; Bonet P
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):754-65. PubMed ID: 6433838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of mexiletine in ventricular arrhythmias.
    Chaudron JM; Luwaert RJ
    Acta Cardiol; 1985; 40(6):589-98. PubMed ID: 2420104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mexiletine in the treatment of ventricular arrhythmias].
    Tanaka T; Kusumoto M; Miyazawa Y; Umemura J; Suwa J; Komatsu Y
    Kokyu To Junkan; 1986 Mar; 34(3):315-9. PubMed ID: 3704375
    [No Abstract]   [Full Text] [Related]  

  • 25. Arrhythmias, hypertension and the elderly: Holter evaluation.
    Celentano A; Galderisi M; Mureddu GF; Garofalo M; Tammaro P; de Divitiis O
    J Hypertens Suppl; 1988 Nov; 6(1):S29-32. PubMed ID: 3216239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.
    Kobayashi A; Yamazaki N; Kobayashi T; Watanabe T; Ito T; Ogawa K
    Jpn Circ J; 1990 Dec; 54(12):1486-96. PubMed ID: 2077145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias.
    Burton JO; Korsheed S; Grundy BJ; McIntyre CW
    Ren Fail; 2008; 30(7):701-9. PubMed ID: 18704819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
    Böcker K; Köhler E; Seipel L; Loogen F
    Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical electrophysiological evaluation of mexiletine].
    Molina L; Colín L; Micheletti T; Blank S; Camacho J
    Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
    Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
    Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.